Oxidative stress during viral infection: A review

Free Radical Biology and Medicine

Volumn 21, Issue 5, 1996, Pages 641-649

  Schwarz, Kathleen B ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b NONE   (United States)

Author keywords

Antioxidants; DNA viruses; Free radicals; Immune response; Pro oxidant cytokines; Retroviruses; RNA viruses; Viral pathogenesis

Indexed keywords

ALPHA INTERFERON; ALPHA TOCOPHEROL; ANTIOXIDANT; ANTIVIRUS AGENT; CYTOKINE; FREE RADICAL; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PYRAN COPOLYMER; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR;

ANIMAL MODEL; CONTROLLED STUDY; DNA VIRUS; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; INFLUENZA VIRUS; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHAGOCYTOSIS; PRIORITY JOURNAL; RETROVIRUS; REVIEW; RNA VIRUS; VIRUS INFECTION; VIRUS PATHOGENESIS;

ANIMALIA; DNA VIRUSES; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; INFLUENZA VIRUS; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0029782304     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/0891-5849(96)00131-1     Document Type: Article

References (76)

1. 1. Pasquier, C.; Olivier, R. Y.; Auclair, C.; Packer, L. Oxidative stress, cell activation and viral infection. (Conference); 1994.
2. 2. Müller, F. Reactive oxygen intermediates and human immunodeficiency virus (HIV) infection. Free Radic. Biol. Med. 13:651-657; 1992.
3. 3. Buhl, K.; Jaffe, H. A.; Holroyd, K. J. Systematic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet 2:1294-1298; 1989.
4. 4. Muller, F.; Rollag, H.; Frøland, S. S. Reduced oxidative burst responses in monocytes and monocyte-derived macrophages from HIV-infected subjects. Clin. Exp. Immunol. 82:10-15; 1990.
5. 5. Gmünder, H.; Eck, H. P.; Benninghoff, B.; Roth, S.; Dröge, W. Macrophages regulate intracellular glutathione levels of lymphocytes. Evidence of an immunoregulatory role of cysteine. Cell Immunol. 129:32-46; 1990.
6. 6. Gloenbock, D. T.; Hampton, R. Y.; Qusesh, R. S.; Takayom, K.; Raetz, C. R. H. Lipid Al-like molecule that antagonize the effects of endotoxin on human monocytes. J. Biol. Chem. 266:19490-19498; 1991.
7. 7. Klempner, M. S.; Dinarello, C. A.; Gallis, J. I. Human leukocytic pyrogen induces release of specific granule contents from human neutrophils. J. Clin. Invest. 61:1330-1336; 1978.
8. 8. Halliwell, B. Oxidants and human disease: Some new concepts. FASEB J. 1:358-364; 1987.
9. 9. Schulze-Osthoff, K.; Baker, A. C.; Vanhaesebroeck, B.; Beyaer, R.; Jacob, W. A.; Fiers, W. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. J. Biol. Chem. 167:5317-5323; 1992.
10. 10. Schreck, R.; Rieber, P.; Baeuerle, P. A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10:2247-2258; 1991.
11. 11. Schreck, R.; Meier, B.; Männel, D. N.; Dröge, W.; Baeuerle, P. A. Dithiocarbamates as potent inhibitors of nuclear factor B activation in intact cells. J. Exp. Med. 175:1181-1194; 1992.
12. 12. Hunt, N. H.; van Reyk, D. M.; Fragonas, J. C.; Jeitner, T. M.; Goldstone, S. D. Redox mechanisms in T cell activation. In: Oxidative Stress Cell Activat. Viral Infect. 1994:237-251.
13. 13. Chaudhri, G.; Clark, I. A.; Hunt, N. H.; Cowden, W. B.; Ceredig, R. Effect of antioxidants on primary alloantigen-induced T cell activation and proliferation. J. Immunol. 137:2646-2652; 1986.
14. 14. Hunt, N. H.; Fragonas, J.-C. Effects of anti-oxidants on ornithine decarboxylase in mitogenically activated T lymphocytes. Biochim. Biophys. 113:261-267; 1992.
15. 15. Hockenbery, D.; Oltvai, Z.; Yin, X.; Milliman, C.; Korsmeyer, S. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241-251; 1993.
16. 16. Hinshaw, V. S.; Olsen, C. W.; Dybahl-Sissoko, N.; Evans, D. Apoptosis: A mechanism of cell killing by influenza A and B viruses. J. Virol. 68:3667-3673; 1994.
17. 17. Laurent-Crawford, A. G.; Krust, B.; Muller, S.; Riviere, Y.; Rey-Cuille, M. A.; Bechet, J. M.; Montagnier, L.; Hovanessian, A. G. The cytopathic effect of HIV is associated with apoptosis. Virology 185:829-839; 1991.
18. 18. Sandstrom, P. A.; Roberts, B.; Folks, T. M.; Buttke, T. M. HIV gene expression enhances T cell susceptibility to hydrogen peroxide-induced apoptosis. Aids Res. Hum. Retroviruses 9(11):1107-1113; 1993.
19. 19. Malorni, W.; Rivabene, R.; Santini, M. T.; Donelli, G. N-Acetylcysteine inhibits apoptosis and decreases viral particles in HIV-chronically infected U937 cells. FEBS Lett. 327(1):75-78; 1993.
20. 20. Levine, B.; Huang, Q.; Isaacs, J. T.; Reed, J. C.; Griffin, D. E. Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature 361:739-742; 1993.
21. 21. Rowe, M.; Peng-Pilon, M.; Huen, D.; Hardy, R.; Croom-Carter, D.; Lundgren, E.; Rickinson, A. B. Upreguladon of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: A B-cell-specific response that is delayed relative to NF-κB activation and to induction of cell surface markers. J. Virol. 68:5602-5612; 1994.
22. 22. White, E.; Sabbatini, P.; Debbas, M.; Wold, W. S.; Kusher, D. I.; Gooding, L. R. The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor alpha. Mol. Cell Biol. 12:2570-2780; 1992.
23. 23. Tarodi, B.; Subramanian, T.; Chinnadurai, G. Epstein-Barr virus BHRF1 protein protects against cell death induced by DNA-damaging agents and heterologous viral infection. Virology 201:404-407; 1994.
24. 24. Peterhans, E. Sendai virus stimulates chemiluminescence in mouse spleen cells. Biochem. Biophys. Res. Commun. 91:383-392; 1979.
25. 25. Peterhans, E.; Grob, M.; Bürge, T.; Zanoni, R. Virus-induced formation of reactive oxygen intermediates in phagocytic cells. Free Radic. Res. Commun. 3:39-46; 1987.
26. 26. Cooperstock, M. O.; Tucker, R. P.; Bouble, J. V. Possible pathogenetic role of endotoxin in Reyes Syndrome. Lancet i(pt. 2 of 2): 1272-1274; 1975.
27. 27. Hennet, T.; Peterhans, E.; Stocker, R. Alterations in antioxidant defences in lung and liver of mice infected with influenza A virus. J. Gen. Virol. 73:39-46; 1992.
28. 28. Brown, R. E.; Koh, S.; Bhuvaneswarran, C.; Brewster, M. Lipid peroxidation and hepatocellular degeneration in Reye's Syndrome. Ann. Clin. Lab. Sci. 12:327-328; 1982.
29. 29. Schwarz, K. B.; Moore, T. J.; Sharma, S.; Clemens, M. G.; Seligman, P. Activated THP-cells depress mitochondrial respiration in HEP G2 cells infected with influenza B virus. Mol. Cell Probes 8:1-7; 1994.
30. 30. Schwarz, K. B.; Larroya, S.; Vogler, C.; Sippel, C. J.; Homan, S.; Cockrell, R.; Schulze, I. Role of influenza B virus in hepatic steatosis and mitochondrial abnormalities in a mouse model of Reye Syndrome. Hepatology 12(1):96-103; 1991.
31. 31. Jacoby, D. B.; Choi, A. M. K. Influenza virus induces expression of antioxidant genes in human epithelial cells. Free Radic. Biol. Med. 16:821-824; 1994.
32. 32. Buffington, G. D.; Christen, S.; Peterhans, E.; Stocker, R. Oxidative stress in lungs of mice infected with influenza A virus. Free Radic. Res. Commun. 16:99-110; 1992.
33. 33. Beck, M. A.; Kolbeck, P. C.; Rohr, L. H.; Shi, Q.; Morris, V. C. Benign human enterovirus becomes virulent in selenium-deficient mice. J. Med. Virol. 43(2):166-170; 1994.
34. 34. Beck, M. A.; Kolbeck, P. C.; Shi, Q.; Rohr, L. H.; Morris, V. C.; Levander, O. A. Increased virulence of a human enterovirus (coxsackievirus B3) in selenium-deficient mice. J. Infect. Dis. 170:351-357; 1994.
35. 35. Oda, T.; Akaike, T.; Hamamoto, T.; Suzuki, F.; Hirano, T.; Maeda, H. Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD. Science 244:974-976; 1989.
36. 36. Suematsu, T.; Kamada, T.; Abe, H.; Kikuchi, S.; Yagi, K. Serum lipid peroxide level in patients suffering from liver diseases. Clin. Chim. Acta 79:267-270; 1977.
37. 37. Higueras, V.; Raya, Á.; Rodrigo, J.; Serra, M.; Romá, J.; Romero, F. J. Interferon decreases serum lipid peroxidation products of hepatitis C patients. Free Radic. Biol. Med. 16:131-133; 1994.
38. 38. Kikkawa, Y.; Yano, S.; Skonz, L. Protective effect of interferon inducers against hyperoxic pulmonary damage. Lab. Invest. 50:62-71; 1984.
39. 39. Vierucci, A.; DeMartino, M.; Graziani, E.; Rossi, M. E.; London, W. T.; Blumberg, B. S. A mechanism for liver cell injury in viral hepatitis: Effects of hepatitis B virus on neutrophil function in vitro and in children with chronic active hepatitis. Pediatr. Res. 10:814-820; 1983.
40. 40. Uehara, M.; Sato, N. Impaired ability of neutrophils to produce oxygen-derived free radicals in patients with chronic liver disease and hepatocellular carcinoma. Hepatology 20:326-330; 1994.
41. 41. Trush, M. A.; Kensle, T. W. An overview of the relationship between oxidative stress and chemical carcinogenesis. Free Radic. Biol. Med. 10:201-209; 1991.
42. 42. Hagen, T. M.; Huang, S.; Curnutte, J.; Fowler, P.; Martinez, V.; Wehr, C. M.; Ames, B. N.; Chisari, F. V. Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 91(26):12808-12812; 1994.
43. 43. Liu, R.; Baldwin, B.; Tennant, B. C.; Hotchkiss, J. H. Elevated formation of nitrate and N-nitrosodimethylamine in woodchucks (Marmota monax) associated with chronic woodchuck hepatitis virus infection. Cancer Res. 51:3925-3929; 1991.
44. 44. Liu, R. H.; Jacob, J. R.; Tennant, B. C.; Hotchkiss, J. H. Nitrite and nitrosamine synthesis by hepatocytes isolated from normal woodchucks (Marmota monax) and woodchucks chronically infected with woodchuck hepatitis virus. Cancer Res. 52:4139-4143; 1992.
45. 45. Dighiero, P.; Reux, I.; Hauw, J. J.; Fillet, A. M.; Courtois, Y.; Goureau, O. Expression of inducible nitric oxide synthase in cytomegalovirus-infected glial cells of retinas from AIDS patients. Neurosci. Lett. 166:31-34; 1994.
46. 46. Zheng, Y. M.; Schafer, M. K.; Weihe, E.; Sheng, H.; Corisdeo, S.; Fu, Z. F.; Koprowski, H.; Dietzschold, B. Severity of neurological signs and degree of inflammatory lesions in the brains of rats with Borna disease correlate with the induction of nitric oxide synthase. J. Virol. 67:5786-5791; 1993.
47. 47. Senba, M.; Nakamura, T.; Itakura, H. Statistical analysis of relationship between iron accumulation and hepatitis B surface antigen. Am. J. Clin. Pathol. 84:340-342; 1985.
48. 48. Zhou, Z.; DeTolla, L.; Custer, P.; London, T. Iron, Ferritin, Hepatitis B surface and core antigens in the livers of Chinese patients with hepatocellular carcinoma. Cancer 59:1430-1437; 1987.
49. 49. Israel, J.; Buetow, K.; Millman, I.; Blumberg, B.; London, W. T. Liver iron content in woodchuck hepatocellular carcinoma. Hepatology 8:1296; 1988.
50. 50. Bannister, W. H.; Federici, G.; Heath, J. K.; Bannister, J. V. Antioxidant systems in tumour cells: The levels of antioxidant enzymes, ferritin, and total iron in a human hepatoma cell line. Free Radic. Res. Commun. 1:361-367; 1986.
51. 51. Di Bisceglie, A. M.; Axiotis, C. A.; Hoofnagle, J. H.; Bacon, B. R. Measurements of iron status in patients with chronic hepatitis. Gastroenterology 102:2108-2113; 1992.
52. 52. González-Amaro, R.; García-Monzón, C.; García-Buey, L.; Moreno-Otero, R.; Alonso, J. L.; Yagüe, E.; Pivel, J. P.; López-Cabrera, M.; Fernández-Ruiz, E.; Sánchez-Madrid, F. Induction of tumor necrosis factor α production by human hepatocytes in chronic viral hepatitis. J. Exp. Med. 179:841-848; 1994.
53. 53. González-Amaro, R.; García-Monzón, C.; García-Buey, L.; Moreno-Otero, R.; Alonso, J. L.; Yagüe, E.; Pivel, J. P.; López-Cabrera, M.; Fernández-Ruiz, E.; Sánchez-Madrid, F. Induction of tumor necrosis factor α production by human hepatocytes in chronic viral hepatitis. J. Exp. Med. 179:841-848; 1994.
54. 54. Guidotti, L. G.; Guilhot, S.; Chisara, F. V. Interleukin-2 and alpha/beta interferon downregulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and -independent pathways. J. Virol. 68:1265-1270; 1994.
55. 55. Meyer, M.; Caselmann, W. H.; Schlüter, V.; Schreck, R.; Hofschneider, P. H.; Baeuerle, P. A. Hepatitis B virus transactivator MHBst: Activation of NF-κB, selective inhibition by antioxidants and integral membrane localization. EMBO J. 11:2991-3001; 1992.
56. 56. Müller, F.; Rollag, H.; Froland, S. S. Reduced oxidative burst responses in monocytes and monocyte-derived macrophages from HIV-infected subjects. Clin. Exp. Immunol. 82:10-15; 1990.
57. 57. Roux-Lombard, P.; Frøland, S. S. Altered functions of peripheral blood monocytes in homosexual males and intravenous drug users with persistent generalized lymphadenopathy. Eur. J. Clin. Invest. 16:262-270; 1986.
58. 58. Segal, A. W. The respiratory burst in monocytes and macrophages. London: Academic Press; 1989:89-100.
59. 59. Staal, F. J. T.; Ela, S. W.; Roederer, M.; Anderson, M. T.; Herzenberg, L. A.; Herzenberg, L. A. Glutathione deficiency and human immunodeficiency virus infection. Lancet 339:909-912; 1992.
60. 60. Eck, H. P.; Gmünder, H.; Hartmann, M.; Petzoldt, D.; Daniel, V.; Dröge, W. Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients. Biol. Chem. Hoppe-Seyler 370:101-108; 1989.
61. 61. Roederer, M., Elasw; Staal, F. J. T.; Herzenberg, L. A.; Herzenberg, L. A. N-Acetylcysteine: A new approach to anti-HIV therapy. AIDS Rev. Hum. Retroviruses 8:209-217; 1992.
62. 62. Roederer, M.; Staal, F. J. T.; Osada, H.; Herzenberg, L. A.; Herzenberg, L. A. CD4 and CD8 T cells with high intracellular glutathione levels are selectively lost as the HIV infection progresses. Int. Immunol. 3:933-937; 1991.
63. 63. Sönnerborg, A.; Carlin, G.; Åkerlund, B.; Jarstrand, C. Increased production of malondialdehyde in patients with HIV infection. Scand. J. Infect. Dis. 20:287-290; 1988.
64. 64. Leff, J. A.; Oppegard, M. A.; Curiel, T. J.; Brown, K. S.; Schooley, R. T.; Repine, J. E. Progressive increases in serum catalase activity in advancing human immunodeficiency virus infection. Free Radic. Biol. Med. 13:143-149; 1992.
65. 65. Staal, J. T.; Roederer, M.; Herzenberg, L. A.; Herzenberg, L. A. Intracellular thiols regulate activation of nuclear factor B and transcription of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 87:9943-9947; 1990.
66. 66. Roederer, M.; Staal, F. J. T.; Raju, P. A.; Ela, S. W.; Herzenberg, A.; Herzenberg, L. A. Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. Proc. Natl. Acad. Sci. USA 87:4884-4888; 1990.
67. 67. Kslebic, T.; Kinter, A.; Poli, G.; Anderson, M. E.; Meister, A.; Fauci, A. S. Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine. Proc. Natl. Acad. Sci. USA 88:986-990; 1991.
68. 68. Harakeh, S.; Jariwalla, R. J.; Pauling, L. Suppression of human immunodeficiency virus replication by ascorbate in chronically and acutely infected cells. Proc. Natl. Acad. Sci. USA 87:1745-1749; 1990.
69. 69. Baruchel, S.; Wainberg, M. A. The role of oxidative stress in disease progression in individuals infected by the human immunodeficiency virus. J. Leukoc. Biol. 52:111-114; 1992.
70. 70. Schreck, R.; Grassmann, R.; Fleckenstein, B.; Baeuerle, P. A. Antioxidants selectively suppress activation of NF-κB by human T-cell leukemia virus type I tax protein. J. Virol. 66:6288-6293; 1992.
71. 71. Dollard, S. C.; Gummuluru, S.; Tsang, S.; Fulz, P. N.; Dewhurst, S. Enhanced responsiveness to nuclear factor kappa B contributes to the unique phenotype of simian immunodeficiency virus variant. J. Virol. 68:7800-7809; 1994.
72. 72. Mihm, S.; Ennen, J.; Pessara, U.; Kurth, R.; Dröge, W. Inhibition of HIV-1 replication and NF-κB activity by cysteine and cysteine derivatives. AIDS 5(5):497-503; 1991.
73. 73. Newman, G. W.; Balcewicz-Sablinska, M. K.; Guarnaccia, J. R.; Remold, H. G.; Silberstein, D. S. Opposing regulatory effects of thioredoxin and eosinophil cytotoxicity-enhancing factor on the development of human immunodeficiency virus 1. J. Exp. Med. 180:359-363; 1994.
74. 74. Suzuki, Y. J.; Aggarwal, B. B.; Packer, L. Alpha-lipoic acid is a potent inhibitor of NF-kappa B activation in human T cells. Biochem. Biophys. Res. Commun. 189:1709-1715; 1992.
75. 75. Dröge, W.; Eck, H.-P.; Mihm, S. HIV-induced cysteine deficiency and T-cell dysfunction - A rationale for treatment with N-acetylcysteine. Immunol. Today 13:211-214; 1992.
76. 76. Holroyd, K. J.; Buhl, R.; Borok, Z.; Roum, J. H.; Bokser, A. D.; Grimes, G. J.; Czerski, D.; Cantin, A. M.; Crystal, R. G. Correction of glutathione deficiency in the lower respiratory tract of HIV seropositive individuals by glutathione aerosol treatment. Thorax 48:985-989; 1993.